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Abstract
The protein kinase regulated by RNA (PKR) is an important mediator of the antiviral and antiproliferative actions of interferon (IFN).
The promoter of the PKR gene contains a novel 15-bp element designated KCS that is required for both basal and IFN-inducible
transcription, with KCS function dependent upon both position and orientation relative to the ISRE element. Novel inducible protein
complexes (iKIBP1, iKIBP2) that require both the KCS and the ISRE element sequences for their formation have been identified and
characterized. Transcription factors Sp1 and Sp3 were found to be KCS-binding proteins by electrophoretic mobility shift analyses (EMSA)
and Sepharose bead-KCS oligonucleotide pull-down assays. However, only Sp3 but not Sp1 was a constituent of the inducible iKIBP
complexes. EMSA also identified STAT1, STAT2, and IRF-9 as components of the iKIBP complexes, indicating that ISGF-3 participates
in iKIBP complex formation. Proteins bound at the KCS element in the absence of ISRE were able to recruit both STAT1 and STAT2 to
the KCS element; recruitment was dependent upon IFN- treatment. Chromatin immunoprecipitation assays revealed that the binding of
Sp3, similar to STAT1 and STAT2, at the PKR promoter in vivo was IFN-dependent, but that Sp1 binding was not dependent upon IFN
treatment. These results, taken together, strongly suggest a role for Sp1 in basal and Sp3 in inducible transcription of PKR and that a potential
function of the KCS element is to facilitate the recruitment of ISGF-3 complex components to the PKR promoter to stimulate transcription.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
The interferon (IFN) family of cytokines plays a central
role in the innate defense against viral infection and patho-
genesis (Samuel, 2001). Among the cellular proteins in-
duced by type I IFN is the RNA-dependent protein kinase
(PKR) (Samuel, 1979; Meurs et al., 1990). PKR catalyzes
the phosphorylation of the  subunit of eukaryotic protein
synthesis initiation factor 2 (eIF-2) on serine residue 51
(Samuel, 1979; Pathak et al., 1988). This PKR-mediated
modification of eIF-2 results in inhibition of initiation of
mRNA translation and represents an important mechanism
of the antiviral actions of IFN (Samuel, 1993; Gale et al.,
2000). PKR also has been implicated in the control of cell
growth, differentiation, and apoptosis (Lengyel, 1993; Cle-
mens and Elia, 1997; Biron and Sen, 2001; Samuel, 2001).
Not unexpected because of the multiple processes in which
PKR is implicated, the expression and activity of the PKR
kinase are regulated at multiple levels (Samuel, 2001). Post-
translational mechanisms that modulate PKR activity in-
clude activation of PKR kinase catalytic function through
RNA-dependent autophosphorylation and modulation of ki-
nase activity by homo- and heteromeric protein–protein
interactions (Samuel, 1979; Kostura and Mathews, 1989;
Thomis and Samuel, 1993; Lee et al., 1994; Cosentino et al.,
1995; Ortega et al., 1996; Patel et al., 1996a,b; Benkirane et
al., 1997; Romano et al., 1998). PKR expression is regulated
at the translational level by an autoregulatory mechanism
(Thomis and Samuel, 1992; Barber et al., 1993) and at the
transcriptional level by induction of PKR gene expression
by IFN (Meurs et al., 1990; Thomis et al., 1992; Tanaka and
Samuel, 1994; Kuhen and Samuel, 1997).
A TATA-less promoter drives the expression of PKR
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(Tanaka and Samuel, 1994; Kuhen and Samuel, 1997).
Comparison of the human PKR and mouse promoter se-
quences led to the identification of a novel element, desig-
nated KCS for kinase conserved sequence, that is located
four basepairs (bp) upstream of a functional interferon-
stimulated response element (ISRE) in both promoters
(Tanaka and Samuel, 1994; Kuhen and Samuel, 1997). The
sequence, position, and orientation of the 15-bp KCS ele-
ment relative to the 13-bp ISRE element is exactly con-
served between the human and mouse PKR promoters. The
ISRE element of the human PKR promoter differs from that
of the mouse Pkr promoter only in the 3-terminal nucleo-
tide position (Tanaka and Samuel, 1994; Kuhen and Sam-
uel, 1997). The KCS element is required for both optimal
basal and IFN-inducible transcription of the PKR gene (Ku-
hen and Samuel, 1997; Kuhen et al., 1998). Movement of
the KCS element 100 bp upstream of the ISRE element
causes a drastic reduction in promoter activity, both basal
and IFN-inducible (Ward and Samuel, 2002). In addition,
the function of the KCS element is dependent on its orientation
relative to the ISRE element (Ward and Samuel, 2002).
Consistent with the notion that KCS functions as a con-
stitutive promoter element, the element mediates constitu-
tive protein binding in a specific manner that correlates with
transcriptional activity (Kuhen et al., 1998; Kuhen and Sam-
uel, 1999). A major complex, designated KBP for KCS
binding protein complex, has been identified and mutational
analysis has established that formation of KBP seen by
electrophoretic mobility shift assays (EMSA) correlates
with transcriptional activation in PKR-reporter transfection
assays (Kuhen et al., 1998). The 5 region of the KCS
element corresponds to a low-affinity Sp1-binding site and
antibody supershift studies identified the Sp1 transcriptional
activator as a component of KBP (Kuhen and Samuel,
1999). However, the identity of additional proteins binding
to the KCS element, and their roles in constitutive and
inducible PKR gene expression, remain unknown. In con-
trast to the constitutive protein binding observed at the KCS
element, the ISRE element of the human PKR promoter
mediates specific binding of the type I IFN-inducible trim-
eric transcription factor complex ISGF-3, which consists of
phosphorylated STAT1 and STAT2 proteins and the non-
STAT protein IRF-9 (Fu et al., 1990; Stark et al., 1998; Hor-
vath, 2000; Levy and Darnell, 2002; Ward and Samuel, 2002).
We previously demonstrated inducible protein binding at
the PKR promoter that requires both the KCS and the ISRE
element sequences (Ward and Samuel, 2002). Furthermore,
two novel complexes, called iKIBP1 and iKIBP2 for induc-
ible KCS/ISRE binding protein complex, were shown to
form on the KCS/ISRE element sequences; both iKIBP
complexes contain the transcription factor STAT1, a con-
stituent of the ISGF-3 complex (Ward and Samuel, 2002).
Additional iKIBP complex components remain unknown, in
part due to limited information with respect to the identity
of proteins that bind to the KCS element. Because formation
of the novel IFN-inducible iKIBP complexes requires both
KCS and ISRE, a functional interplay between proteins that
bind at the two elements is suggested. To explore this
possibility, we examined by EMSA and pull-down analyses
the functional relationship between Sp-family and ISGF-3
complex proteins that bind in vitro at the KCS and ISRE
element sequences, respectively, and then by chromatin
immunoprecipitation the binding of factors at the human PKR
promoter region in vivo. The results establish that both Sp1
and Sp3 bind the KCS element, but that only Sp3 partici-
pates in the IFN-inducible complex formation with ISGF-3
at the PKR promoter elements both in vitro and in vivo.
Results
ISGF-3 participates in the formation of novel inducible
complexes that require both the KCS and the ISRE
elements
To verify that the ISRE element of the human PKR
promoter bound ISGF-3 proteins as anticipated in an induc-
ible manner, the ISRE element alone first was used as the
oligonucleotide probe (I-probe) in EMSA analyses. Consis-
tent with well-established observations for IFN-inducible
genes, selective protein binding to the ISRE element of the
PKR promoter was dependent on IFN treatment (Fig. 1A).
As anticipated, antibodies against either STAT1, STAT2, or
IRF-9 (p48) eliminated inducible complex formation with
the ISRE I-probe, firmly establishing this induced complex
as ISGF-3 (Fig. 1A, Lanes 3-5). Competition analyses re-
vealed that a 100-fold molar excess of either unlabeled
oligonucleotide corresponding to the KCS and ISRE ele-
ments together (KI-oligonucleotide) or I-oligonucleotide,
but not competitor corresponding to the KCS element (K-
oligonucleotide), was able to compete formation of the
IFN-inducible ISGF-3 complex seen with 32P-labeled I-
probe (Ward and Samuel, 2002; data not shown).
Our previous results demonstrated constitutive protein
binding at the KCS element alone (Kuhen and Samuel,
1999; see also Fig. 2). In addition, the formation of two
novel IFN-inducible complexes designated iKIBP1 and
iKIBP2 was observed that required both elements, KCS and
ISRE, of the human PKR promoter (Ward and Samuel,
2002). The transcription factor STAT1 was identified as a
component of the iKIBP complexes (Ward and Samuel,
2002). We therefore sought to determine whether the re-
maining components of ISGF-3, STAT2, and IRF-9 (p48)
were part of the iKIBP complexes. When an oligonucleotide
containing both the KCS and ISRE elements was used in
EMSA tests (KI-probe), inducible (iKIBP) protein binding
was detected only with extracts prepared from IFN-treated
cells (Fig. 1A, Lanes 6 and 7). Consistent with studies with
the K-probe (Kuhen and Samuel, 1999; Ward and Samuel,
2002), formation of the KBP complex at the KCS element
using the KI-probe likewise was not dependent on IFN
treatment (Fig. 1A, Lane 6). The iKIBP1 and iKIBP2 com-
554 S. Visosky Ward, C.E. Samuel / Virology 313 (2003) 553–566
plex signals were relatively comparable in intensity when
analyzed with extracts from IFN-treated human GM2767
cells (Fig. 1A, Lane 7; Fig. 1B, Lane 1). Antibodies against
either STAT1 or STAT2 (Fig. 1A, Lanes 8, 9) and IRF-9
(p48) (Fig. 1A, Lane 10 and Fig. 1B, Lane 2) all abolished
the formation of the iKIBP complexes. Antibody against
IRF-9 (p48) also caused the appearance of two supershifted
complexes which likely correspond to shifted iKIBP1 and
iKIBP2 (Fig. 1B, Lane 2). In contrast, antibody against the
IRF-1 transcription factor (Miyamoto et al., 1988) did not
affect iKIBP complex formation under conditions where
anti-STAT1 antibody abolished formation of the iKIBP
complexes (Fig. 1C, Lanes 3, 4), despite the ability of IRF-1
to bind to the ISRE element of the human PKR promoter
(data not shown). Furthermore, antibody against IRF-1 also
did not affect KBP complex formation (Fig. 1C, Lane 3).
Similar results were obtained with nuclear extracts from
IFN-treated human amnion U cells (data not shown). These
results firmly establish the ISGF-3 transcription factor com-
plex proteins as components of both the iKIBP1 and the
iKIBP2 complexes.
The Sp3 transcription factor binds to the KCS element of
the PKR promoter
Because formation of the iKIBP complexes required the
KCS element in addition to the ISRE element and included
ISGF-3 proteins, we next examined protein binding at the
Fig. 1. Supershift analysis of protein complex formation at the ISRE element alone (I-probe) and at the KCS element together with the ISRE element
(KI-probe). (A) EMSA was carried out using nuclear extracts (10 g protein) prepared from untreated (Lanes 1, 6) or IFN-treated (Lanes 2–5; Lanes 7–10)
GM2767 cells. Extracts were incubated with the I-probe (Lanes 1–5) or KI-probe (Lanes 6–10). Antibodies against STAT1, STAT2, and IRF-9 were used
in supershift analyses as noted. The KBP, ISGF-3, and iKIBP complexes are indicated by arrows. Asterisks in Lane 10 indicate supershifted complexes. (B)
Protein complexes observed with the KI-probe and extracts from IFN-treated GM2767 cells in the absence (Lane 1) or presence (Lane 2) of anti-IRF-9
antibody were resolved by a longer gel run to distinguish supershifted complexes (indicated by asterisks) from the iKIBP complexes. (C) Supershift analysis
as described above except using antibodies against IRF-1 (Lane 3) and STAT1/ (Lane 4).
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KCS element with the hope of gaining further insight into
the composition of the iKIBP1 and iKIBP2 complexes.
Nuclear extracts from untreated GM2767 cells were ana-
lyzed by EMSA, with either the K- or the KI-oligonucleo-
tide probe (Fig. 2). As previously described (Kuhen and
Samuel, 1999), both KBP and KBP complex formation was
observed with the K-probe alone (Figs. 2A and B, Lanes 1);
specificity of complex formation was ascertained by com-
petition with wild-type K-oligo, but not mutant 6A K-oligo
or wild-type I-oligo (Fig. 2A, Lanes 2-4). For KBP, two
distinct band shifts were observed with GM2767 cell ex-
tracts (Fig. 2A), consistent with prior results with U cell
extracts (Kuhen and Samuel, 1999), suggesting that one or
more of the proteins that comprise the two KBP complexes
likely differ from each other. A similar pattern of band shift
formation was seen with the KI-probe, except that KBP
complex mobility appeared more compact in nature relative
to that with the K-probe (Fig. 2B, Lane 4). Because the KCS
element includes a binding site for Sp1 and Sp3 (Suske,
1999), the effect of antibodies specific for these factors on
complex formation was examined. Antibody against Sp1
abolished formation of only the slower migrating KBP com-
plex detected with either the K- or the KI-probe (Fig. 2B,
Lanes 2 and 5). Formation of the KBP complex was not
affected by anti-Sp1 antibody (Fig. 2B, Lanes 2 and 5). By
contrast, antibody against the Sp3 transcription factor
(Kingsley and Winoto, 1992) abolished formation of both
the faster migrating KBP complex and also the KBP com-
plex seen with both the K-probe and the KI-probe (Fig. 2B,
Lanes 3, 6). These results demonstrate that the Sp3 tran-
Fig. 2. Sp3 binds to the PKR promoter KCS element and participates in iKIBP complex formation. (A) Competition analysis of constitutive protein binding
to the KCS element (K-probe). Nuclear extracts (10 g protein) from untreated GM2767 cells were incubated with 32P-labeled K-probe in the absence (Lane
1) or presence (Lanes 2–4) of 100-fold excess of unlabeled competitor. (B) Supershift analysis of constitutive protein binding to the KCS element (K-probe)
and the KCS element together with the ISRE element (KI-probe) was carried out with nuclear extracts (10 g protein) from untreated GM2767 cells.
Supershift analyses were carried out using polyclonal antibodies against Sp1 (Lanes 2, 5) and Sp3 (Lanes 3, 6). The KBP and KBP complexes are indicated
by brackets. (C) Analysis of constitutive transcription factors as iKIBP complex components. EMSA analysis was with nuclear extracts (10 g protein) from
untreated (Lane 1) or IFN-treated (Lanes 2–5) GM2767 cells. Supershift analyses were carried out using polyclonal antibodies against Sp1 (Lane 3) and Sp3
(Lane 4), or a combination of both anti-Sp1 and anti-Sp3 antibodies (Lane 5). The KBP, ISGF-3, and iKIBP complexes are as indicated.
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scription factor binds to the KCS element of the PKR
promoter and establishes Sp3 as a component of the lower
KCS band shift and Sp1 as a component of the upper KCS
band shift.
Sp3 but not Sp1 is a component of the iKIBP1 and
iKIBP2 complexes
Because both the Sp1 and the Sp3 transcription factors
were capable of binding to the KCS element as tested with
the K-probe, we next asked whether either Sp1 or Sp3, or
both factors, were constituents of the iKIBP1 and iKIBP2
complexes (Fig. 2C). EMSA analysis was performed using
the KI-probe and extracts prepared from untreated or IFN-
treated GM2767 cells. Antibody against Sp1 did not affect
formation of either the iKIBP1 or the iKIBP2 complex,
despite the ability of anti-Sp1 antibody to abolish formation
of the upper component of the KBP complex (Fig. 2C, Lane
3). Two complexes with mobility similar to KBP remained
in the presence of anti-Sp1 antibody; the lower most likely
corresponds to the faster migrating KBP complex that in-
cludes Sp3, while the upper most likely corresponds to
ISGF-3 (Fig. 2C, Lane 3).
By contrast, when antibody against Sp3 was used, for-
mation of both iKIBP1 and iKIBP2 was abolished (Fig. 2C,
Lane 4). In addition, the faster migrating KBP complex was
abolished by the anti-Sp3 antibody (Fig. 2C, Lane 4). The
only remaining band shift presumably consisted of a mix-
ture of the slower migrating KBP complex and ISGF-3,
which migrate to a similar position in the gel (Fig. 2C, Lane
4). A combination of both anti-Sp1 and anti-Sp3 antibodies
also resulted in only one remaining band shift, the ISGF-3
complex (Fig. 2C, Lane 5).
Multimerization of the KCS element increases PKR
promoter activity
Studies with reporter constructs possessing three copies
of the KCS element in the context of a single ISRE element
indicated that both basal and IFN-inducible PKR promoter
activities were increased by KCS multimerization (Ward
and Samuel, 2002). To determine in a systematic manner
the effect of KCS dosage on PKR promoter activity, CAT-
reporter constructs containing a single ISRE element and
either no, one, two, three or four KCS elements in the
background of the parent p63 (Wt) plasmid were prepared
and analyzed in human amnion U cells (Fig. 3). Quite
unexpectedly, p63 (insK) with two KCS elements did not
show any increase in either basal or IFN-inducible promoter
activity relative to the p63 (Wt) parent with one KCS copy.
However, both basal and IFN-inducible promoter activities
were substantially increased for both the p63 (insKx2) con-
struction that possesses three copies of the KCS element and
the p63 (insKx3) construction with four KCS copies (Fig.
3). For reference, p63 (delK) without a KCS element
showed very low promoter activity relative to the p63 (Wt)
construct with a single KCS element (Fig. 3), as earlier
reported (Kuhen and Samuel, 1997).
Fig. 3. Effect of KCS multimerization on basal and IFN-inducible PKR promoter activity. Shown on the left is a schematic representation of CAT-reporter
plasmids obtained by insertion of KCS elements into the wild-type minimal human PKR promoter construct p63 (Wt) that contains the KCS and ISRE
elements. The p63 (delK) construct that lacks the KCS element, but possesses a functional ISRE element, was also included in transfection analyses. The
right side shows the promoter activities observed in human amnion U cells transfected with the indicated wild-type and mutant reporter constructs. Open bars
refer to cells left untreated, and hatched bars refer to cells treated with IFN- for 24 h. Relative promoter activity is shown normalized to basal activity of
the p63 (Wt) construct. To control for transfection efficiency, cells were cotransfected with the pGL2-Control plasmid as an internal reference. The
promoter-less plasmid vector pCAT-Basic served as a negative control in all transfection experiments. pCAT-Control, in which CAT-reporter gene expression
is driven by the simian virus 40 promoter and enhancer, served as a positive control (data not shown).
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STAT1 and STAT2 are recruited to proteins bound at the
KCS element
Based on the promoter activity results obtained from
KCS element multimerization experiments (Fig. 3), a
KCS element oligomer containing three copies of KCS
was used as the platform in a pull-down DNA-binding
assay. This strategy was undertaken to test for the pos-
sible association of ISRE-binding proteins with proteins
bound at the KCS element (Fig. 4). Nuclear extracts from
untreated or IFN-treated human GM2767 or mouse MEF
cells were incubated with KCS element DNA linked to
Sepharose beads, followed by immunoblot analysis of
bound material to detect the presence of interacting pro-
tein factors (Fig. 4A).
As a control to assess the specificity of the KCS pull-
down DNA-binding assay, unbound material remaining
from experiments with beads that either lacked or possessed
Fig. 4. Interaction of STATs with proteins bound at the KCS element. (A) Schematic diagram of the DNA-binding pull-down assay. The KCS element
conjugated to Sepharose beads was incubated with nuclear extracts prepared from untreated or IFN-treated cells. Bound proteins were eluted and analyzed
by immunoblotting. (B) EMSA analysis of unbound material from beads that either lacked or possessed a conjugated KCS element. 35 l (10%) of unbound
material was supplemented with 0.5 g of poly(dI:dC) and directly analyzed by EMSA using the K- or I-probe, as indicated. Unbound fraction from the KCS
element pull-down assay using nuclear extracts from IFN-treated MEF cells (Lanes 1–4) or IFN-treated GM2767 cells (Lanes 5–8) was analyzed. (C) Nuclear
extracts (150 g) prepared from untreated or IFN-treated human GM2767 cells were incubated with beads without conjugated DNA or conjugated to the KCS
element. One-half of the bound protein sample (Lanes 2, 3 and Lanes 5, 6) was analyzed by immunoblotting with anti-Sp1 and anti-Sp3 antibodies. Input
nuclear extract (7.5 g) is shown as a marker (Lanes 1, 4). Asterisks in the lower panel indicate the Sp3 protein isoforms. (D) DNA-binding pull-down
analysis was carried out using nuclear extracts from IFN-treated GM2767 cells, followed by immunoblot analysis of bound materials (Lanes 2, 3) using
antibodies against STAT1, IRF-9, or IRF-1. Nuclear extract input material is shown in Lane 1. (E) KCS element DNA-binding pull-down assays were
performed using nuclear extracts (150 g) prepared from untreated or IFN-treated mouse MEF cells. Two-thirds of the bound material fraction eluted from
beads that lacked or possessed the conjugated KCS DNA element (Lanes 2, 3 and 5) were analyzed by immunoblotting with anti-STAT1 and anti-STAT2
antibodies. Nuclear extract input material (20 g) from IFN-treated (Lane 1) and untreated (Lane 4) MEF cells is shown.
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a linked KCS element DNA oligomer was analyzed by
EMSA with K- and I-oligonucleotide probes (Fig. 4B). The
KCS and ISRE elements of the PKR promoter bind distinct
protein factors including Sp1 and Sp3 at the KCS element
and ISGF-3 (STAT1, STAT2, IRF-9) at the ISRE element
(Figs. 1 and 2) (Kuhen and Samuel, 1999; Ward and Sam-
uel, 2002). Unbound material from IFN-treated mouse MEF
cells (Fig. 4B, Lanes 1–4) and human GM2767 cells (Fig.
4B, Lanes 5–8) was analyzed by EMSA. When beads lack-
ing a coupled KCS element DNA oligomer were used, both
KBP complex (Fig. 4B, Lanes 1 and 5) and ISGF-3 complex
(Fig. 4B, Lanes 3 and 7) formation were detected in the
unbound fraction using the K-probe and the I-probe, respec-
tively. When beads with linked triple KCS element DNA
were used, KBP complex formation was drastically reduced
with the K-probe using the unbound fraction (Fig. 4B,
Lanes 2 and 6). However, ISGF-3 complex formation with
the I-probe was still seen using unbound material from
experiments with beads possessing a coupled KCS element
DNA oligomer (Fig. 4B, Lanes 4 and 8). Finally, when the
triple KCS element oligomer was used as a Kx3 probe, no
IFN-inducible shift was observed in EMSA tests; only a
basal band shift complex was seen that was competed by
single K wild-type monomer but not mutant 6A monomer or
wild-type I (data not shown). These results taken together
indicate a specific depletion of proteins that directly bind to
the KCS element and that the multimerized KCS oligomer
does not possess an ISGF-3-binding site.
To confirm that Sp1 and Sp3 proteins known from
EMSA tests to be part of KBP protein complexes bound
directly at the KCS element, blots of the material pulled
down with Sepharose beads from GM2767 extracts were
probed with anti-Sp1 and anti-Sp3 antibodies (Fig. 4C). The
levels of Sp1 (top panel) and Sp3 (bottom panel) were
comparable in nuclear extract input material from untreated
as compared to IFN-treated cells (Fig. 4C, Lanes 1 and 4).
Both Sp1 and Sp3 were detected in bound material eluted
from beads with linked KCS element DNA (Fig. 4C, Lanes
3 and 6). But, neither Sp1 nor Sp3 was detected when beads
that lacked a conjugated KCS element DNA oligomer were
used in the pull-down (Fig. 4C, Lanes 2 and 5). The levels
of Sp1 and Sp3 found associated with beads with linked
KCS element DNA were comparable for nuclear extracts
prepared from untreated as compared to IFN-treated cells
(Fig. 4C, Lanes 3 and 6). This finding is fully consistent
with EMSA results that showed IFN-independent Sp1- and
Sp3-containing KBP complex formation (Fig. 2). Finally,
both large and small isoforms of the Sp3 protein (Hagen et
al., 1994; Lania et al., 1997; Suske, 1999) were bound to
KCS element containing beads (Fig. 4C, Lanes 3 and 6,
bottom panel).
Because formation of the iKIBP1 and iKIBP2 complexes
detected by EMSA required both the KCS and ISRE elements
and IFN treatment (Figs. 1 and 2), and because ISGF-3 con-
stituent proteins participated in the formation of the iKIBP
complexes (Figs. 1), we examined bound material eluted from
beads with linked KCS element DNA for the presence of
STAT and IRF proteins that bind at the ISRE element but not
directly at the KCS element. Surprisingly, STAT1 protein was
found specifically associated with KCS element beads when
extracts from IFN-treated GM2767 cells were used (Fig. 4D,
Lane 3, top panel). By contrast, with beads lacking the KCS
element oligomer, no significant STAT1 protein was detected
in the pull-down assay (Fig. 4D, Lane 2, top panel). Neither
IRF-9 nor IRF-1 were detected in bound material eluted from
Sepharose beads either possessing or lacking the KCS element
DNA (Fig. 4D, Lanes 2 and 3, center and bottom panels,
respectively). However, both IRF proteins were readily de-
tected in the GM2767 cell nuclear extract input starting mate-
rial (Fig. 4D, Lane 1, center and bottom panels). IRF-1 and
IRF-9 proteins were not readily detectable in nuclear extracts
prepared from human GM2767 cells not treated with IFN (data
not shown).
We next examined nuclear extracts from untreated and
IFN-treated mouse MEF cells in the DNA pull-down binding
assay (Fig. 4E) to assess the generality of the findings seen
with human GM2767 cells (Fig. 4D). As was seen for the
GM2767 cells, STAT1 specifically bound to beads with linked
KCS element DNA when nuclear extract from IFN-treated
mouse cells was tested in the pull-down assay (Fig. 4E, Lane
3, top panel). In addition, STAT2 also was detected in the
bound material eluted from beads linked to KCS element DNA
when extracts from IFN-treated mouse cells were tested (Fig.
4E, Lane 3, bottom panel). A similar pattern of STAT2 binding
was observed with nuclear extracts from IFN-treated STAT1
null MEF cells and from IFN-treated GM2767 cells (data not
shown). No significant association of either STAT1 or STAT2
was detected with beads that lacked a coupled KCS element
oligomer used as a control (Fig. 4E, Lane 2). In addition,
STAT1 and STAT2 were not detected in bound material when
nuclear extracts from untreated MEF cells were used (Fig. 4E,
Lane 5). However, not unexpectedly, lower levels of STAT1
and STAT2 were present in the nuclear extracts prepared from
untreated MEF cells compared to IFN-treated cells (Fig. 4E,
Lanes 1 and 4; data not shown). Taken together, our results
strongly suggest that the two members of the STAT family of
transcription factors (STAT1 and STAT2), but not two mem-
bers of the IRF family of transcription factors (IRF-1 and
IRF-9), are capable of specific interaction with protein com-
ponents of the complex bound at the KCS element of the PKR
promoter.
Treatment with IFN- increases the association of STAT1
with KCS-binding proteins
Because IFN treatment resulted in greater nuclear levels
of STAT1 and STAT2 compared to untreated cells (Fig.
4E), we next examined more directly the effect of IFN-
treatment on the association of STAT1 with the KBP-bind-
ing protein complex. Cells first were primed by treatment
with IFN- to increase the level of proteins involved in
formation of the ISGF-3 complex (Levy et al., 1990), as
559S. Visosky Ward, C.E. Samuel / Virology 313 (2003) 553–566
illustrated by STAT1 (Fig. 5, Lanes 1 and 2). To assess the
effect of treatment with IFN- on the ability of STAT1 to
associate with proteins bound at the KCS element linked to
beads, whole-cell extracts were prepared from IFN--
primed and IFN--primed  IFN--treated MEF cells. The
level of STAT1 in whole-cell extracts prepared from IFN-
-primed cells was comparable to the level of STAT1 in
whole-cell extracts prepared from IFN--primed  IFN--
treated MEF cells (Fig. 5, compare Lanes 3 and 6). How-
ever, the amount of STAT1 that bound to beads linked to
KCS element DNA was substantially greater for whole-cell
extract prepared from IFN--primed  IFN--treated MEF
cells as compared to MEF cells that were only primed with
IFN- (Fig. 5, compare Lanes 5 and 8). As was seen with
nuclear extracts, no significant binding of STAT1 to Sepha-
rose beads that lacked the KCS element was detected when
whole-cell extract prepared from either IFN--primed or
IFN--primed IFN--treated MEF cells was used (Fig. 5,
Lanes 4 and 7). These results are consistent with a require-
ment for STAT1 activation by IFN- to achieve optimal
association with KCS-binding proteins.
Protein binding to the PKR promoter in vivo
Our results obtained in vitro by both EMSA and DNA-
binding pull-down assays revealed a differential association
of Sp1 and Sp3 with KCS element KBP and iKIBP com-
plexes. This finding prompted us to examine the binding of
Sp1 and Sp3 proteins to the PKR promoter in vivo under
physiologically relevant conditions. For this purpose, chro-
matin immunoprecipitation (ChIP) analysis was carried out.
The results obtained for Sp1 and Sp3 were compared to
those obtained for STAT1 and STAT2 (Fig. 6). The location
of primer pairs used to amplify the PKR promoter region is
shown by the Fig. 6A schematic. STAT1 and STAT2 pro-
teins were observed by ChIP analysis to be associated with
the PKR promoter in vivo in an IFN-dependent fashion (Fig.
6B, Lanes 3, 4). By contrast, binding of the Sp1 transcrip-
tion factor was not modulated by IFN treatment (Fig. 6B,
Lanes 3 and 4). Surprisingly, however, the association of the
Sp3 transcription factor with the PKR promoter region chro-
matin was modulated by IFN treatment in a manner similar
to that seen for the STAT1 and STAT2 factors (Fig. 6B,
Lanes 3, 4). These results strongly suggest that stable asso-
ciation of the Sp3 protein with the PKR promoter in vivo
requires the presence of IFN-induced factors, likely includ-
ing components of the ISGF-3 complex bound at the ISRE
element.
Discussion
The RNA-dependent protein kinase PKR plays important
roles in a variety of cellular and physiological processes,
including the antiviral actions of interferons, regulation of
cell growth and differentiation, and apoptosis (Biron and
Sen, 2001; Samuel, 2001). Our study was undertaken to
obtain mechanistic insight into the transcriptional regulation
of the PKR gene. We have gained understanding of the
protein composition of the iKIBP complexes bound at the
PKR promoter, both in vitro and in vivo, and we have
determined a possible functional relationship between pro-
teins that bind to the KCS and ISRE elements. Several
important points emerge from our results reported herein.
First, the transcription factor Sp3 was discovered to bind
to the KCS element of the PKR promoter. Furthermore, the
KBP complex bound at the KCS element could be resolved
into two components, one faster migrating that contained
Sp3 and the other more slowly migrating in EMSA gels that
contained Sp1 (Fig. 2). Earlier results had identified Sp1 as
a factor capable of binding to the KCS element (Kuhen and
Samuel, 1999), a finding confirmed herein. Importantly, the
Sp3 transcription factor, but not Sp1, was a demonstrable
component of the inducible iKIBP1 and iKIBP2 complexes
detected by EMSA in vitro (Fig. 2). The finding that Sp1
was only present in one form of the KBP band shift complex
and was not found in iKIBP further suggests the possibility
that iKIBP complex formation involves specific protein–
protein interactions between proteins binding to the KCS
and ISRE elements. For example, it appears that only the
forms of KBP complex containing Sp3 participate in iKIBP
complex formation. Although Sp1 and Sp3 both bind the
same GT- and GC-box sequences with similar affinities
(Hagen et al., 1994), it is interesting to note that the KCS
element sequence includes a central GC-rich sequence in
addition to the low-affinity Sp1-binding site present in the
5 region of the element.
Second, STAT1, STAT2, and IRF-9 were found to be
components of the iKIBP1 and iKIBP2 complexes (Fig. 1).
Because all components of the ISGF-3 complex were found
to be iKIBP complex components, our results suggest that
Fig. 5. Recruitment of STAT1 to proteins bound at the KCS element
depends on IFN- treatment. KCS element pull-down assays were per-
formed using whole-cell extracts (500 g) prepared from IFN--primed, or
IFN--primed  IFN--treated, MEF cells (right panel, Lanes 3–8).
Bound proteins eluted from beads that lacked (Lanes 4, 7) or possessed
(Lanes 5, 8) a conjugated KCS element were analyzed by immunoblotting
with anti-STAT1 antibody. Whole-cell extract input material (5 g) from
IFN- primed (Lane 3) or IFN--primed  IFN--treated (Lane 6) MEF
cells is shown. The left panel shows the relative levels of STAT1 in
whole-cell extracts prepared from untreated (Lane 1) or IFN--primed
(Lane 2) MEF cells.
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ISGF-3 (Fu et al., 1990; Schindler et al., 1992) participates
in the formation of both iKIBP1 and iKIBP2 (Ward and
Samuel, 2002). The transcriptional activator IRF-1 was not
found to be a component of either the iKIBP1 or the iKIBP2
complex, despite the ability of IRF-1 to bind to the ISRE
element of the PKR promoter. These results are consistent
with a selective protein composition of the iKIBP com-
plexes.
Third, proteins bound at the KCS element of the PKR
promoter were able to interact with both STAT1 and
STAT2 in the absence of ISRE as revealed by Sepharose
bead KCS DNA-binding pull-down assays (Fig. 4). How-
ever, an interaction between KCS binding proteins and
IRF-9 was not detected. These results are fully consistent
with earlier findings of Darnell and co-workers (Qureshi et
al., 1995), in which following IFN- treatment, STAT1 and
STAT2 were seen to form heterodimers unassociated with
IRF-9 (p48) until ISRE binding. Association of STAT1 with
proteins bound at the KCS element was dependent upon
IFN- treatment (Fig. 5). Modulation of interactions be-
tween STATs and other transcriptional regulators has been
reported to occur as a result of STAT phosphorylation
(Kisseleva et al., 2002).
Fourth, it is most significant that the STAT1, STAT2,
Sp1, and Sp3 transcription factors all were found associated
with the PKR promoter in vivo under physiologically rele-
vant and intact cell conditions, as revealed by ChIP analyses
(Fig. 6). Unlike the constitutive binding of the Sp1 protein
that was not modulated by IFN treatment, the association in
vivo of Sp3 proteins, similar to that of STAT1 and STAT2,
with the PKR promoter region chromatin was dependent on
IFN treatment. Thus, one intriguing possibility is that the
Sp3 transcriptional regulator contributes to PKR promoter
activation by facilitating formation of a transcription factor
complex that includes both ISGF-3 and KCS-binding pro-
teins, as exemplified by iKIBP complex formation. Presum-
ably the assembly of an iKIBP complex including ISGF-3
and Sp3 represents a step in the pathway of recruitment of
the polymerase II machinery to drive transcription of the
PKR gene.
Our findings reported herein are consistent with the no-
tion that the KCS and ISRE DNA elements of the PKR
Fig. 6. Binding of transcription factors to the PKR promoter region in vivo. (A) Schematic diagram (drawn to scale) illustrating the location of primer pairs
used to amplify the PKR promoter region by chromatin immunoprecipitation (ChIP) analysis. Nested PCR was performed using primer pairs 1 and 3 for
first-round synthesis and primer pairs 2 and 3 for the second round of amplification. (B) ChIP analysis was performed, using either no antibody (Lanes 1,
2) or antibody (Lanes 3, 4), against Sp1, Sp3, STAT1, or STAT2 as indicated to the right of the four panels. DNA isolated from input chromatin was amplified
as a control (Lanes 5, 6). Both chromatin prepared from untreated (Lanes 1, 3, 5) and IFN-treated (Lanes 2, 4, 6) human amnion U cells was analyzed. A
size standard marker is shown in Lane 7.
561S. Visosky Ward, C.E. Samuel / Virology 313 (2003) 553–566
promoter function as a unit (Figs. 1–3), as first indicated by
the drastic reduction of both basal and IFN-inducible pro-
moter activity seen upon movement of the KCS element
100 bp upstream of the ISRE element (Ward and Samuel,
2002). Our results therefore suggest a model whereby pro-
teins bound at the KCS element function in part to recruit
activated components of the ISGF-3 transcription factor
complex to the vicinity of the ISRE element, followed by
subsequent formation of the ISGF-3 complex and binding
via IRF-9. Possibly the drastic decrease in both basal and
IFN-inducible PKR promoter activity observed when the
KCS element is moved 100 bp away from the ISRE
element is caused by the recruitment of activated proteins to
a region too far away from the ISRE element (Ward and
Samuel, 2002). Alternatively, the close proximity of KCS
and ISRE elements may serve to stabilize a cooperative
binding of their respective protein complexes which other-
wise is prevented by spatial separation. Consistent with the
notion of cooperativity, it should be noted that DNA bind-
ing of the IFN-inducible iKIBP1 and iKIBP2 complexes
required the presence of both the KCS and the ISRE ele-
ment sequences and that iKIBP complex composition is
selective in including Sp3 and ISGF-3 proteins, but exclud-
ing Sp1 and IRF-1. Furthermore, IFN-inducible binding of
Sp3 to the PKR promoter is observed in vivo, yet Sp3 itself
is not known to be regulated by IFN.
Our results regarding the Sp1 transcription factor and the
PKR promoter may be compared to those for the ICAM-1
and hMCP-1 promoters. Sp1 has been reported to interact
with STAT1 in the context of adjacent GAS and GC-box
elements in the ICAM-1 promoter (Look et al., 1995). Con-
stitutive binding of Sp1 to a GC-box present in the hMCP-1
gene promoter region has also been observed in vitro, but
protection of this site in vivo was dependent on treatment
with IFN- and coincided temporally with protection of a
downstream GAS element (Zhou et al., 1998). Although
Sp1 was not found to be a constituent of the iKIBP com-
plexes, it is possible that the Sp1 transcription factor par-
ticipates in the recruitment of STAT proteins to the PKR
promoter.
Our studies revealed that both long and short isoforms of
Sp3 (Hagen et al., 1994; Suske, 1999) were able to bind to
the KCS element. The significance of multiple-size iso-
forms of Sp3 is not yet fully understood (Suske, 1999).
Possibly the multiple forms of Sp3-containing complexes
that we saw, the faster migrating KBP complex and KBP
on the KCS element and the iKIBP1 and iKIBP2 complexes
on the KCS/ISRE elements, reflect the presence of different
Sp3 isoforms. It is interesting to note that a pattern of band
shift formation similar to that seen with the KCS element
also was observed when a GC-box oligonucleotide was used
as the probe in EMSA analyses (Suske, 1999). Conceivably
the faster migrating KBP and KBP complexes contain the
long and short isoforms of the Sp3 protein, respectively,
although the availability of Sp3 isoform specific reagents
will be required to test this possibility. A similar situation
may exist for the iKIBP complexes. However, the possibil-
ity that yet unidentified KCS-binding proteins contribute to
the formation of the multiple Sp3-containing protein com-
plexes seen on the KCS and KCS/ISRE elements cannot be
ruled out.
It is tempting to speculate that protein–protein interac-
tions between Sp3 and additional members of the STAT
family of transcriptional regulators may occur, which could
either increase or decrease transcriptional activity depen-
dent upon the specific settings. Interestingly, the Sp3 tran-
scription factor has been reported to function as either a
transcriptional activator or repressor, depending on the cel-
lular and promoter contexts and interacting proteins (Hagen
et al., 1994; Lania et al., 1997; Philipsen and Suske, 1999;
Suske, 1999). In this context, it would be of interest to
characterize the potential interactions between the Sp3 tran-
scription factor and the members of the STAT family of
proteins, as well as to assess their effect on transcriptional
activity of the PKR promoter.
The KCS element so far is limited to the PKR promoter
and has not been found in other IFN-/ regulated genes.
The notion that a subset of IFN-regulated genes, in this case
PKR requires an additional cis-acting element (KCS) and
trans-acting factors together with the ISRE element and
ISGF-3 factor for optimal IFN-induced expression is con-
sistent with recent findings involving the SWI2-SNF2 chro-
matin remodeling complex (Huang et al., 2002). BRG1, a
key component of the SWI2–SNF2 complex, selectively
activates transcription of a subset of IFN- inducible genes,
9-27 and IFI27, but not other IFN-inducible genes tested, by
a mechanism that involves interaction with STAT2. The
STAT2 subunit of ISGF-3 selectively recruits GCN5 his-
tone acetylase but not CBP, p300, or PCAF, and GCN5 is
necessary for the expression of several IFN- inducible
genes (Paulson et al., 2002). Based on the role of the KCS
element in both basal and IFN-inducible transcription of the
PKR gene, it is tempting to speculate that proteins bound at
the KCS element may aid in recruitment of additional fac-
tors beyond STAT1 and STAT2 to the PKR ISRE element.
Materials and methods
Construction of reporter gene plasmids
The pCAT-Basic promoter-less plasmid (Promega) con-
taining the chloramphenicol acetyltransferase (CAT) gene
was used for construction of reporter plasmids containing
the KCS and ISRE elements of the human PKR promoter.
The human PKR promoter CAT-reporter constructs p63
(Wt) and p63 (delK) were as previously described (Kuhen
and Samuel, 1999). Dosage mutants containing two, three,
or four KCS elements in the p63 (Wt) background were
generated by introduction of the wild-type KCS element
into the blunted PstI site of the parent plasmid in a stepwise
fashion to conserve the spacing of 4 bp between all copies
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of the KCS element. The sequence of the double-stranded
oligonucleotide used to generate the KCS element dosage
mutant constructions was 5CTGCAGGGAAGGCG-
GAGTCCAAGG 3. The structures of all constructions
were confirmed by Sanger sequencing.
Cell maintenance and interferon treatment
Human amnion U cells, mouse embryo fibroblast (MEF)
cells, and the human fibroblast cell strain GM2767 were
maintained in Dulbecco’s modified Eagle’s medium
(DMEM) as previously described (Samuel and Knutson,
1983; Ward and Samuel, 2002). For EMSA, KCS element
pull-down assays and ChIPs, human amnion U cells, or
GM2767 cells were primed with 100 U/ml human IFN-
(PBL) for 18 h, followed by treatment with 1000 U/ml
IFN- for 30 min (Levy et al., 1990). MEF cells were
primed with 100 U/ml mouse IFN- (PBL) for 18 h, fol-
lowed by treatment with 1000 U/ml IFN-A/D for 30 min.
Transfection and reporter analyses
U cells were transfected by the DEAE-dextran-chloro-
quine phosphate transfection method (Luthman and Mag-
nusson, 1983) using 10 g of the CAT reporter gene con-
struct and 5 g of pGL2-Control (Promega) as the internal
reference plasmid. The pCAT-Control (Promega) plasmid
containing the simian virus 40 promoter and enhancer and
the promoter-less pCAT-Basic plasmid were routinely ana-
lyzed in all transfection experiments as controls. All DNA
plasmids used in transfections were purified by cesium
chloride equilibrium centrifugation and were analyzed by
agarose gel electrophoresis to verify plasmid integrity.
Treatment with IFN- (1000 U/ml) was carried out begin-
ning 24 h posttransfection. Cells were harvested 48 h post-
transfection; extracts were prepared, and luciferase and
CAT activities were determined as previously described
(Kuhen and Samuel, 1997; George and Samuel, 1999; Ward
and Samuel, 2002). The protein concentration of extracts
was determined by the modified Bradford method (Bio-
Rad). CAT activity was quantified after thin-layer chroma-
tography by use of a Bio-Rad GS-525 molecular imager
system.
Nuclear extract preparation
Nuclear extracts were prepared from GM2767 or MEF
cells according to published procedures (Bromberg et al.,
1999). Cells were scraped into ice-cold phosphate-buffered
saline and collected by centrifugation. Cell pellets were
suspended in three volumes of lysis buffer [20 mM HEPES,
pH 7.9; 10 mM KCl; 1 mM EDTA, pH 8.0; 0.2% NP-40
(v/v); 0.1 mM Na3VO4; 1 mM PMSF; 1 mM DTT; 10%
glycerol (v/v); and 1% protease inhibitor cocktail (v/v;
Sigma)] and incubated on ice for 10 min. Cell suspensions
were gently pipetted up and down to ensure complete lysis
of cells, and then lysates were centrifuged at 14,000 g for 5
min at 4°C to obtain nuclear pellets. Nuclear pellets were
washed two times with cell lysis buffer [minus NP-40 and
minus protease inhibitor cocktail] and then resuspended in
two volumes of nuclear extract buffer [20 mM HEPES, pH
7.9; 10 mM KCl; 1 mM EDTA, pH 8.0; 1 mM PMSF; 1 mM
DTT; 1 mM Na3VO4; 420 mM NaCl; 20% glycerol (v/v);
and 10% protease inhibitor cocktail (v/v; Sigma)]. Nuclei
were extracted for 30 min at 4°C with gentle agitation,
followed by centrifugation at 14,000 g for 5 min at 4°C to
obtain nuclear extracts.
Whole-cell extract preparation
To prepare whole-cell extracts, MEF cells were washed,
scraped, and pelleted as described above. Cell pellets were
suspended in two to three pellet volumes of whole-cell
extract buffer [20 mM HEPES, pH 7.9; 10 mM KCl; 1 mM
EDTA, pH 8.0; 1 mM PMSF; 1 mM DTT; 1 mM Na3VO4;
5 mM NaF; 400 mM NaCl; 0.5% NP-40; 20% glycerol
(v/v); and 1% protease inhibitor cocktail (v/v; Sigma)],
incubated on ice for 10 min, and gently pipetted up and
down to ensure complete lysis of cells. Cell suspensions
were transferred to 4°C for 30 min with gentle agitation to
extract nuclei, followed by centrifugation at 14,000 g for 5
min at 4°C to obtain whole-cell extracts.
Electrophoretic mobility shift assay
The sequence of the wild-type double-stranded KCS
oligonucleotide used as the 32P-end-labeled probe or unla-
beled competitor was as given under the plasmid construc-
tion section. The sequences of the mutant KCS(mt6A),
wild-type ISRE, and KCS/ISRE (KI) oligonucleotides used
as the double-stranded probes or competitors in EMSA
analysis were as follows, with substitution mutations indi-
cated by underlined type:
mutant KCS(mt6A), 5CTGCAGGGAAAGCGGAG-
TCCAAGG 3;
wild-type ISRE, 5CCAAGGGGAAAACGAAACT-
GCAG 3;
KI, 5CTGCAGGGAAGGCGGAGTCCAAGGGG-
AAAACGAAACTGCAG 3.
For protein–DNA-binding reactions, 10 g of nuclear ex-
tract protein (Bradford) was incubated with 32P-labeled
probe for 25 min at room temperature in a 25 l reaction
containing 1 g poly(dI:dC); 20 mM HEPES, pH 7.9; 1 mM
MgCl2; 40 mM KCl; 0.1 mM EGTA, pH 8.0; 1 mM DTT;
and 10% glycerol (v/v). Samples were analyzed by electro-
phoresis using 5% native polyacrylamide gels with 0.5
Tris–borate–EDTA buffer. Gels were prerun at 4°C for at
least 30 min prior to sample loading, and electrophoresis
was carried out for approximately 1 h 15 min or 2 h 30 min.
Gels were then dried and autoradiography performed. For
supershift analyses, rabbit polyclonal antisera against
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STAT2 and IRF-1 and a monoclonal antibody against IRF-9
were generously provided by C. Schindler (Columbia Uni-
versity), R. Pine (New York Public Health Research Insti-
tute), and N.C. Reich (State University of New York, Stony
Brook), respectively. Rabbit polyclonal antiserum against
Sp3 was the kind gift of G. Suske (Philipps-Universita¨t
Marburg) or purchased from Upstate Biotechnology. Rabbit
polyclonal antibodies against STAT1 (E-23) and Sp1 were
from Santa Cruz Biotechnology and Upstate Biotechnology,
respectively. Incubation with antibodies was on ice for 45
min prior to addition of 32P-labeled probe.
KCS element pull-down assay
A double-stranded oligonucleotide containing three cop-
ies of the wild-type KCS element [5AAGGCTGCA(GG-
GAAGGCGGAGTCCAAGG)3 3, with the KCS element
indicated by underlined type] and biotinylated on the ()-
strand was attached to Streptavidin Sepharose beads accord-
ing to the manufacturer’s (Amersham Pharmacia) protocol,
using 10 g of oligonucleotide per 25 l of packed bead
volume. The beads were washed twice with buffer A [20
mM HEPES, pH 7.9; 1 mM MgCl2; 40 mM KCl; 0.1 mM
EGTA, pH 8.0; 1 mM DTT; and 10% glycerol (v/v)],
blocked in the same buffer supplemented with 0.5% BSA at
room temperature for 30 min, and then washed three times
with buffer A before use. Incubation was with 150 g
nuclear extract protein or 500 g whole-cell extract protein
in a 350 l volume containing buffer A and 7 g poly(dI:
dC) at room temperature for 30 min. Beads were pelleted,
and the supernatant containing unbound proteins was stored
at 70°C for analysis by electrophoretic mobility shift
assay. The beads were then washed twice with buffer A.
Bound proteins were eluted in 25 l of buffer B [20 mM
HEPES, pH 7.9; 10 mM KCl; 1 M NaCl; 1 mM EDTA, pH
8.0; 1 mM DTT; 1 mM PMSF; 1 mM Na3VO4; 10%
glycerol (v/v); and 1% protease inhibitor cocktail (v/v;
Sigma)] for 20 min at room temperature and analyzed by
Western immunoblotting.
Immunoblot analysis
Proteins were fractionated on 10% SDS–PAGE gels,
transferred to nitrocellulose membranes, and probed with
appropriate dilutions of primary antibodies in phosphate-
buffered saline containing 3% skim milk. Detection was
with horseradish peroxidase conjugated anti-rabbit IgG or
anti-mouse IgG secondary antibodies using an ECL detec-
tion kit according to instructions provided by the manufac-
turer (Amersham Pharmacia). Polyclonal antibodies used to
detect mouse STAT1/ and STAT2 (M-22 and L-20,
respectively) were from Santa Cruz Biotechnology; all other
antibodies were as described above for electrophoretic mo-
bility shift assays.
Chromatin immunoprecipitation assay
ChIP analysis was carried out as described (Orlando et
al., 1997; Biggin, 1999; Toth and Biggin, 2000; Clayton et
al., 2000; Takahashi et al., 2000) with the following mod-
ifications. Human amnion U cells were grown to confluence
in 90-mm dishes and fixed with 1% formaldehyde (diluted
from a freshly prepared 11% stock in 100 mM NaCl; 1 mM
EDTA, pH 8.0; 0.5 mM EGTA, pH 8.0; and 50 mM
HEPES, pH 8.0) for 10 min at room temperature. Glycine
was added to a final concentration of 125 mM, followed by
incubation for 5 min at room temperature. Fixed cells were
scraped into phosphate-buffered saline and pelleted. Cells
were resuspended in 1 ml of cell lysis buffer [10 mM
HEPES, pH 7.5; 1 mM EDTA, pH 8.0; 0.5% NP-40; 0.1
mM Na3VO4; 5 mM NaF; 1 mM PMSF; and 1% protease
inhibitor cocktail (v/v; Sigma)] and incubated on ice for 10
min. Nuclei were isolated by centrifugation at 14,000 g for
5 min at 4°C and resuspended in 1 ml of nuclear lysis buffer
[50 mM HEPES, pH 7.5; 140 mM NaCl; 1 mM EDTA, pH
8.0; 1% NP-40; 1 mM Na3VO4; 5 mM NaF; 1 mM PMSF;
and 1% protease inhibitor cocktail (v/v; Sigma)]. The nu-
clear suspension was sonicated to solubilize and shear chro-
matin to an approximate maximal length of 12–15 kb and
centrifuged at 14,000 g for 5 min at 4°C. A 200-l aliquot
of the chromatin solution was digested with 200 U of
HindIII in a 1 ml volume containing 50 mM NaCl; 10 mM
Tris–Cl; pH 7.9; 10 mM MgCl2; 1 mM DTT; 100 g BSA;
0.1% SDS; and 1 mM PMSF for 3 h at 37°C, with digestion
confirmed by agarose gel electrophoresis. Chromatin di-
gests were adjusted to a final concentration of 137 mM
NaCl; 1 mM EDTA, pH 8.0; 1% NP-40; and 1% protease
inhibitor cocktail (v/v; Sigma) and precleared with protein
A Sepharose (Sigma) for 1 h at 4°C. Precleared chromatin
was incubated overnight at 4°C with anti-STAT1 (Santa
Cruz Biotechnology), anti-STAT2 (C. Schindler), anti-Sp1,
or anti-Sp3 antibodies (Upstate Biotechnology), followed
by incubation with protein A Sepharose (Sigma) for 2 h at
4°C. Beads were pelleted and washed once with nuclear
lysis buffer (minus protease and phosphatase inhibitors),
twice with nuclear lysis buffer adjusted to 500 mM NaCl
(minus protease and phosphatase inhibitors), twice with
buffer containing 5 mM Tris–Cl, pH 8.0; 125 mM LiCl; 0.5
mM EDTA, pH 8.0 and 0.25% NP-40, and then once with
TE buffer. Beads were suspended in 200 l of TE buffer,
treated with 10 g RNase A for 30 min at 37°C and 100
g/ml proteinase K at 37°C overnight, followed by
crosslink reversal at 65°C for 6 h, phenol-chloroform ex-
traction, and ethanol precipitation. DNA isolated from im-
munoprecipitated material was amplified by nested PCR.
The same () primer (primer 3) was 5AGACCCGCG-
GCTTCGGGAGA 3. The first-round () primer (primer
1) was 5CGCACTCTGGATCCAGCGCCAAT 3 (20 cy-
cles of 94°C 1 min, 63°C 30 s, 72°C 1 min); the second-
round () primer (primer 2) was 5ATCCAGCGCCAATT-
TACCCCAATCCCGT 3 (20 cycles of 94°C 1 min, 65°C
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30 s, 72°C 1 min). As a control, 1/100 of digested input
chromatin was processed and analyzed similarly, without
immunoprecipitation. First-round and second-round PCR
resulted in products of 141 and 131 bp, respectively.
Materials
Unless otherwise specified, all materials and reagents
were as described previously (Kuhen and Samuel, 1997,
1999; Kuhen et al., 1998; Ward and Samuel, 2002).
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